GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HLB Science Inc (XKRX:343090) » Definitions » EV-to-FCF

HLB Science (XKRX:343090) EV-to-FCF : (As of Apr. 30, 2024)


View and export this data going back to 2020. Start your Free Trial

What is HLB Science EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, HLB Science's Enterprise Value is ₩54,534.36 Mil. HLB Science does not have enough years/quarters to calculate its Free Cash Flow for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate HLB Science's EV-to-FCF at this moment.

The historical rank and industry rank for HLB Science's EV-to-FCF or its related term are showing as below:

XKRX:343090' s EV-to-FCF Range Over the Past 10 Years
Min: -22.59   Med: 0   Max: 0
Current: -18.02

XKRX:343090's EV-to-FCF is ranked worse than
100% of 391 companies
in the Biotechnology industry
Industry Median: 4.47 vs XKRX:343090: -18.02

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-04-30), HLB Science's stock price is ₩3460.00. HLB Science does not have enough years/quarters to calculate its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate HLB Science's PE Ratio at this moment.


HLB Science EV-to-FCF Historical Data

The historical data trend for HLB Science's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HLB Science EV-to-FCF Chart

HLB Science Annual Data
Trend Dec22 Dec23
EV-to-FCF
-11.86 -13.05

HLB Science Quarterly Data
EV-to-FCF

Competitive Comparison of HLB Science's EV-to-FCF

For the Biotechnology subindustry, HLB Science's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HLB Science's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, HLB Science's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where HLB Science's EV-to-FCF falls into.



HLB Science EV-to-FCF Calculation

HLB Science's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=54534.355/
=


HLB Science  (XKRX:343090) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

HLB Science's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=3460.00/
=

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


HLB Science EV-to-FCF Related Terms

Thank you for viewing the detailed overview of HLB Science's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


HLB Science (XKRX:343090) Business Description

Traded in Other Exchanges
N/A
Address
66, Achasan-ro, 6th Floor, Seongdong-gu, Seoul, KOR
HLB Science Inc develops biological new drugs to treat infectious diseases. Its product pipelines includes DD-S052P, DD-A279, and DD-A514.

HLB Science (XKRX:343090) Headlines

No Headlines